Lv13
48 积分 2024-06-26 加入
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
4小时前
待确认
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma
1天前
已完结
Gain of function in CDKN1C
2天前
已完结
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
17天前
已完结
Drug Design, Development and Therapy
1个月前
已关闭
Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
1个月前
已完结
Predictive biomarkers for cancer therapy with PARP inhibitors
1个月前
已完结
PARP Inhibitors for Breast Cancer Treatment
1个月前
已完结
Talazoparib: First Global Approval
2个月前
已完结
Olaparib
2个月前
已完结
皖公网安备34019202002308
